Skip to main content
PLOS Neglected Tropical Diseases logoLink to PLOS Neglected Tropical Diseases
. 2025 Sep 26;19(9):e0013551. doi: 10.1371/journal.pntd.0013551

Comparing diagnostic methods for historical arbovirus outbreaks: Insights from 19th century “dengue” epidemics

Timothee Bonifay 1,2,*, Mathieu Nacher 1,2, Clémence Bonnefoy 1, Benjamin Rossi 3, Edouard Hallet 1, Philippe Abboud 1, Guillaume Bellaud 4, Nathalie Dournon 5, Aurélia Henn 6, Adrien Lemaignen 7, Liem Binh Luong Nguyen 8, Diane Sanderink 9, Gaelle Walter 1, Alexandre Bleibtreu 10, Loïc Epelboin 1,2
Editor: Joshua Anzinger11
PMCID: PMC12468935  PMID: 41004510

Abstract

This study reexamines historical “dengue” epidemics of the 18th and 19th centuries, suggesting that chikungunya virus (CHIKV), rather than dengue virus (DENV), may have been responsible for many of these outbreaks. While “dengue” was identified as a tropical disease in the 19th century, its exact characteristics remain unclear, and some descriptions align more closely with CHIKV, known for its distinctive symptom of joint pain. Three approaches were used to investigate these historical epidemics: (A) Expert opinion provided a contextualized and comprehensive analysis but faced criticism for its subjective nature (B) Clinical Score Application allowed for greater objectivity and a more stringent diagnosis, although it was limited by the need for a complete description (C) Double Proofreading: Two expert groups independently reviewed the articles, which enhanced objectivity but also led to greater variability in the results. The study suggests that CHIKV was mainly responsible for the epidemics historically attributed to “dengue”. It highlights the challenges of diagnosing diseases from historical records. It also raises the possibility that other alphaviruses, like mayaro virus, could be involved, but CHIKV remains the primary candidate. This study offers intriguing insights into pathogen identification in historical epidemics, emphasizing the importance of a combined approach for a more precise understanding of past diseases and their evolution.

Author summary

In the 18th and 19th centuries, several large epidemics were described under the name “dengue,” but their true cause remains uncertain. At that time, neither the dengue virus (DENV) nor the chikungunya virus (CHIKV) had been discovered. Yet the symptoms reported in historical records—especially severe joint pain—often resemble what is now known to be caused by CHIKV. In this study, we reassessed the cause of these historical outbreaks using three complementary methods: expert contextual review, a standardized clinical scoring system, and independent double-review by two teams of physicians. Each method has strengths and limitations, and while results varied somewhat, all pointed toward CHIKV as the most likely cause of many of these past epidemics. We also considered whether other viruses, such as Mayaro virus, might have been involved, but found little evidence to support this. Our study highlights the challenges of diagnosing diseases in the absence of laboratory tests and underlines how modern clinical knowledge can help reinterpret historical data. This approach offers new insights into the origins and spread of arboviral diseases and helps improve our understanding of how similar epidemics have occurred and evolved over the past two centuries.

Introduction

The 19th century was a pivotal period for medical discoveries. The germ theory of diseases gained widespread acceptance, epidemiology emerged as a scientific discipline, and the medical lexicon was standardized through numerous treatises and dictionaries. In the context of colonization and globalization, infectious and tropical diseases such as cholera, plague, and yellow fever became prominent areas of study [1]. Among these, a new disease termed “dengue” began to be investigated. In hindsight, the “dengue” described in the 19th century encompassed a group of arboviral diseases that were not yet understood. Today, we know that arboviral infections share common symptoms such as fever, myalgia, fatigue, and headache, while each virus also has distinct characteristics. For instance, some flaviviruses, including yellow fever virus (Orthoflavivirus flavi, YFV) and dengue virus (Orthoflavivirus denguei, DENV), are notable for their hemorrhagic manifestations [2]. DENV comprises four serotypes DENV 1 to DENV 4 that circulate in tropical regions in an endemic-epidemic pattern and can cause severe forms, including dengue hemorrhagic fever (DHF). Alphaviruses, on the other hand, are known for their joint tropism and include chikungunya virus (Alphavirus chikungunya, CHIKV), Mayaro virus (Alphavirus mayaro, MAYV), and O’nyong-nyong virus (Alphavirus onyong, ONNV). CHIKV is the most prominent representative of the Alphavirus genus [3]. Its transmission occurs through two main cycles:

  • (A)

    a sylvatic cycle in Africa (and now parts of Asia), involving a variety of reservoir and vector species, resulting in sporadic cases or small outbreaks that are often asymptomatic or mildly symptomatic;

  • (B)

    a peri-urban or urban transmission cycle mainly transmitted by Aedes aegypti and Aedes albopictus, characterized by sudden, large-scale epidemics with high attack rates. These epidemics typically subside gradually.

The names, “dengue” and “dengue fever” was attached to distinct short-duration febrile diseases before their viral etiology was established. The clinical term “dengue” entered the medical literature in the American hemisphere in the 19th century describing a short-duration febrile exanthem. It was not an English word, but a Spanish homonym of the African Swahili “kidinga pepo,” sometimes pronounced “denga” or “dyenga” This was the name given to epidemics of a disabling febrile arthritis, now known as chikungunya, during outbreaks in East Africa in 1823 and again in 1870 [4]. In 1881, James Christie, a Scottish-trained physician attached to the Sultan of Zanzibar, in the 1860s-70s published a report explicitly linking an 1823 East African outbreak of kidinga pepo to the outbreak in 1827 – 28 of “dengue” in the Americas [5]. In commenting on the dispersal of what we now know to be CHIKV, Christie described reports that the 1823 Zanzibar epidemic had spread East to Gujarat, India, then on to Calcutta and in 1824 to Rangoon. He added that there had been a similar spread of the 1823 “dengue” epidemic, this time westwards. In 1827, this epidemic reached St.Thomas in the West Indies. Christie states “I am of the opinion that both the disease and its designation were imported in the West Indian Islands direct from the East Coast of Africa” [5]. He noted it was then that the medical term “dengue” was introduced into the West Indies as a Spanish homynym of the African word. Another observer, contemporary to the West Indian epidemic, agreed. He wrote: “when the dengue” reached New Orleans in 1828, “the disease alluded to is supposed to have been brought from Africa, with some slaves imported into the Havana. In that place it obtained the name of Dingee, Dengue, Danga, etc. It was there very prevalent and also in Barbadoes, where it received the name of Dandy fever, from the stiffened form and dread of motion in patients” [6].

The systematic study of arboviruses began in the early 20th century, following the discovery of vector transmission and the identification of viruses [7]. The number of recognized arboviruses increased from seven in 1930 to over 350 by the 1970s, and more than 500 nowadays [8]. This research was primarily driven by the United States, first through the Rockefeller Foundation and later by Yale University in the 1960s [7]. In 1971, Dr. Carey proposed revisiting descriptions of “dengue” epidemics predating 1950 (date of DENV’s virological identification), hypothesizing that many were actually caused by CHIKV [9]. This reinterpretation was later expanded by Dr. Halstead, who documented the 1827–1828 epidemic in the Caribbean as a likely historical chikungunya outbreak, underlining the need to revisit historical uses of the term ‘dengue’ and their associated clinical syndromes [10].

Given the resurgence of arbovirus epidemics over the past decade, particularly in the Americas, revisiting this historical perspective is of interest. Assuming that some of the “dengue” epidemics described in the 19th century were not caused by DENV, CHIKV appears as a plausible alternative explanation. It is a deliberate choice by the authors to refer specifically to focus on CHIKV rather than broader arthritogenic Alphaviruses. To date, no other alphavirus, including MAYV and ONNV, has caused recurrent epidemics of comparable scale and frequency to those of CHIKV.

This study aimed to reclassify the “dengue” epidemics of the 18th and 19th centuries using three analytical methods. To provide clarity, we use the term “dengue” to refer to the nosological entity described in the 19th century, based solely on symptomatic clinical observations. When we refer to DENV or CHIKV, we mean the infections as they are defined today, based on virological diagnostic methods. Although no 19th-century arbovirus epidemics were biologically confirmed, these terms are used to contextualize the findings within the framework of current scientific knowledge.

Methods

Bibliographical research

The study period for this research spanned 100 years, from 1779 (the year of the first scientific description of a “dengue” epidemic) to 1880 (the year of the last described “dengue” epidemic in the 19th century, excluding one recorded in Australia in 1897). A narrative review of “dengue” epidemics was conducted, utilizing all available articles and books related to “dengue” or its synonyms. Historical encyclopedias on “dengue” were also consulted to supplement the bibliography [1121].

Inclusion criteria:

  • For the period 1831–1880: Articles that described an outbreak and used the term “dengue”.”

  • For the period 1779–1830 (when the term “dengue” was not yet in use): articles describing an epidemic that were later cited (post-1830) in encyclopedias or other sources as referring to a “dengue” epidemic.

Exclusion criteria:

  • Articles not digitized.

  • Absence of the author at the outbreak location.

  • Insufficiently detailed clinical descriptions.

  • Inconsistent clinical descriptions.

No language restrictions were applied. Digitized articles and books were sourced from various platforms, including PubMed, HathiTrust, the National Library of Scotland, Persée, the Bibliothèque numérique Medica, Smithsonian Libraries, and Google Books.

First method: Expert opinion

Expert opinion is a common approach in historical reviews [9,10,22]. Articles were read and analyzed by a medical doctor (T.B.) with expertise in arboviruses to provide an expert perspective. This analysis aimed to propose a subjective interpretation of these “dengue” epidemics, considering not only the medical context but also the historical, social, and political factors of the studied period.

Second method: Application of a clinical score

A previously developed clinical diagnostic score was used to differentiate between DENV and CHIKV infections (Fig 1). This score was based on clinical data collected during the 2014–2015 CHIKV and 2013 DENV outbreaks in French Guiana [23]. Clinical variables favouring CHIKV included joint and back pain, while those favouring DENV included headache, muscle pain, nausea/vomiting, diarrhea, and haemorrhagic signs. The score’s cut-off was adjusted to achieve a sensitivity of 89% for DENV diagnosis and a specificity of 91%, improving the distinction between the two infections. DENV infection was associated with scores ranging from -9 to 0. CHIKV infection corresponded to scores ranging from +1 to +5 (Table 1). Clinical variables of interest required for score calculation were extracted from 19th-century articles.

Fig 1. Sensitivity (in grey) and specificity (in black) curves for a dengue diagnosis.

Fig 1

Based on values obtain from the CHIKV vs. DENV clinical prediction score. The figures indicate the value calculated with the 95% confidence interval.

Table 1. Diagnostic score for DENV and CHIKV virus infection.

Diagnostic score DENV - CHIKV
Headache -1
Joint pain +5
Myalgia -2
Rachialgia +1
Nausea and/or vomiting -1
Diarrhoea -2
Haemorrhage -3

Third method: Double proofreading

Selected articles were randomly assigned to two adjudication committees composed of physicians specializing in infectious and tropical diseases. The first committee included infectiologists from mainland France (B.R., G.B., N.D., A.H., A.L., L.B.L.N., and A.B.), while the second consisted of physicians based in French Guiana (P.A., G.W., C.B., D.S., and L.E.) with clinical expertise in arboviral infections. The expert who had conducted the initial review (T.B.) was excluded from this process.

Each article was independently evaluated by two physicians, one from each committee, so that every article was reviewed twice by two distinct adjudicators. These physicians had unrestricted access to the full text of the articles but were blinded to each other’s assessments. Based on their independent review, each adjudicator categorized the article according to one of four predefined outcomes: 1. DENV infection; 2. CHIKV infection; 3. Other pathology; 4. Insufficient information to decide.

Results

Selected articles

Out of the 103 publications initially included, 41 were excluded due to the lack of a digitized version, particularly those from the 1820s describing outbreaks in India (Fig 2). Articles were published in various regional or national journals dating from the 19th century or earlier (Table 2). Of the 64 digitized articles describing epidemics, 31 were selected after applying the exclusion criteria [4,6,16,19,2450]. Nine of the excluded articles described outbreaks where the authors were not present at the time of the events (reported cases). Most of the selected publications focused on the epidemics of 1827–1828 and 1871–1873. The majority of the descriptions were written in English. The contributing physicians represented a range of nationalities, including those from the United Kingdom, the United States, France, Spain, Prussia, and the Netherlands. All inter-tropical zones were represented in the analysed articles.

Fig 2. Flow chart of the study.

Fig 2

Table 2. List of newspapers in which articles on “dengue” fever have been published.

List of newspapers
The British Medical Journal
Charleston medical journal and review
The Edinburgh medical and surgical journal
The London medical and physical journal
The Madras monthly journal of medical science
New-York medical and physical journal
Archives de médecine navale
Transactions of the Medico-Chirurgical Society of Edinburgh
Army health reports and medical documents
Army health reports and medical documents
The Medical and surgical reporter
The Edinburgh medical journal
The Calcutta journal of medicine
Atlanta medical and surgical journal
The Southern medical and surgical journal
Indian medical gazette

First method: Expert opinion

General epidemiological context.

Origin of outbreaks: “Dengue” did not appear to be endemic in the Americas. At the onset of epidemics, authors often suggested an imported origin, primarily via maritime routes [32,34]. In 1827, Dr. Stedman proposed that the disease was introduced through the deep-water port of St. Thomas in the United States Virgin Islands, located in the northeastern Caribbean Sea and serving as a key gateway for ships entering the Americas. He hypothesized that “dengue” had been brought from the African continent. This theory was later supported by Dr. Christie, who, 50 years later, linked the disease’s introduction to the transatlantic slave trade [5,33]. Similarly, the 1870 epidemic on the Indian subcontinent was believed to have been imported from Zanzibar. It is challenging to differentiate between the potential successive introductions of DENV or CHIKV. It appears that DENV was introduced in the 18th century [25]. However, it is difficult to determine whether it was circulating endemically during that period.

Estimation of prevalence: Several authors attempted to estimate the attack rate of “dengue” during outbreaks. In Havana, it was reported that 30–40% of the population contracted the disease within a six-week period [34]. During the 1871–1873 epidemic, attack rate estimates ranged from 70–80%, with some areas experiencing infection rates as high as 94% [5,47,51,52]. Most authors agreed that “dengue” epidemics affected individuals regardless of age, sex, or origin, suggesting a lack of herd immunity and supporting the theory that it was a non-endemic disease [31].

Mortality: All accounts described “dengue” as a highly contagious disease with an exceptionally low mortality rate [31]. During an epidemic in Cádiz, Spain, in 1784, Dr. Cubillas even referred to the disease as “la piadosa” (“the pious one”) due to its mild nature [26]. This characterization stood in stark contrast to other contemporaneous epidemics, which often had significantly higher mortality rates. These epidemiological observations pointed to a mild arboviral infection (excluding YFV) but did not provide definitive evidence to differentiate between DENV and CHIKV.

Symptoms suggestive of CHIKV or DENV infection.

Hemorrhagic syndrome: Due to their traumatic experiences with YFV epidemics, physicians were particularly vigilant in identifying and reporting hemorrhagic symptoms [25]. Despite tens of thousands of cases reported during the 1827–1828 and 1871–1873 periods, no hemorrhagic episodes were documented. In contrast, the 1780 and 1850 outbreaks included several cases of gingivorrhagia, metrorrhagia, hematemesis, and hemoptysis, supporting a diagnosis of DENV.

Rash: Rashes are frequently mentioned in the literature. Typically, the infection begins with a palmoplantar scarlet rash, sometimes accompanied by edema and/or pruritus in the affected areas. This initial rash was often followed around day 8 by a secondary measles-like rash. Both rashes could be accompanied by scaling. However, these dermatological signs were not specific enough to differentiate between the two diseases.

Acute joint pain: In 1779, Dr. Bylon (himself infected) described inflammatory stiffness in the ankles, with a marked increase in joint stiffness in the morning. Joint pain was a prominent feature in nearly all accounts from the 1827–1828 and 1871–1873 epidemics. Dr. Stedman, in 1827, detailed the progression of symptoms: “A person in perfect health would suddenly feel a stiffness, close to pain, in one of his fingers, most often the little finger. The stiffness increased and was followed by intense pain that spread rapidly throughout the hand, from the arm to the shoulder. In a few hours, the fingers of both hands became swollen, stiff, and painful, making any attempt to flex the joints unbearable” [33].

Joint pain emerged as the most disabling symptom of the infection, strongly favoring CHIKV. Similarly, Dr. Nicholson, in 1827, described patients as “unable to walk” with fingers so swollen that “all manual work [was] impossible” [35]. By 1873, Dr. Morice considered gouty arthritis a potential differential diagnosis [19]. In the same year, physicians in Mauritius began to regard joint swelling as a pathognomonic sign of the outbreak [49]. The presence of joint swelling, strongly associated with CHIKV, was notably absent in DENV infections.

Chronic joint pain: Many articles from the 1827–1828 and 1871–1873 epidemics describe chronic joint pain lasting several weeks or months, a hallmark feature of CHIKV. In contrast, during the 1780 and 1850 epidemics, the reported symptoms included diffuse pain, sometimes involving the joints, but without chronicity. These episodes presented a milder clinical picture with less emphasis on joint involvement, favoring a diagnosis of DENV.

Atypical signs: Some less commonly reported symptoms have also been documented. For instance, Dr. Cock noted in 1827 that “the lobes of the ears were also much affected and painful” during the initial phase of the disease [29]. This unusual manifestation may suggest ear chondritis, potentially linked to the synovial tropism characteristic of CHIKV [53].

Historical authors interrogation.

As early as the 19th century, some physicians expressed doubts about the nature of this new disease termed “dengue”.” Some believed the term referred to multiple distinct diseases, while others saw it as encompassing a variety of manifestations. In 1828, Dr. Ruan proposed that “dengue” represented a new disease, though he acknowledged its similarities to Dr. Rush’s “bilious remittent fever” of 1780, now recognized as the first documented DENV epidemic [31].

Similarly, Dr. Stedman identified chronic joint pain as the key difference between “dengue” and bilious remittent fever (e.g., malaria), as such symptoms were absent from Dr. Rush’s accounts [33]. During the 1860 “dengue” epidemic in Martinique, Dr. Ballot, who had previously encountered “dengue” in West Africa, highlighted notable distinctions: “The muscular pains and arthralgias do not seem so intense, [...] In no case were there swellings of the extremities or convalescences so long [...]” [41].

Synonyms used in various descriptions could generally be categorized into two groups: those emphasizing articular involvement and those focusing on non-articular symptoms (Tables 3 and 4). The widespread confusion reflected in many accounts supports the hypothesis that these outbreaks likely involved a mix of CHIKV and DENV cases.

Table 3. Example of a synonym given to “dengue” between 1780 and 1880.
CHIKV DENV
Ephemeral Arthritic Fever Ore (1825) Bilious Remitting fever Rush (1780)
Rhumatismus febrilis Squaer (1828) Neuralgic fever Campbel (1851)
Peculiar Arthritic Emanthem Nicholson (1828) Epidemic neuralgia Anderson (1851)
Exanthesis Arthrosia Good (1829) Break bone fever Arnorld (1850)
Joint fever in tropical countries Thaly (1665)
Eruptive articular fever Sheriff (1872)
Table 4. Proposed classification of “dengue” epidemics that occurred between 1779 and 1880 as DENV or CHIKV infection.
CHIKV DENV
Bylon Indonesia 1779 Rush USA 1780
Ore India 1825 Cubillas Spain 1784
Cock West Indies 1827 De castilla Spain 1784
Maxwell West Indies 1827 Anderson USA 1850
Ruan West Indies 1827 Arnold USA 1850
Squaer West Indies 1827 Campbell USA 1850
Stedman West Indies 1827 Ballot West Indies 1860
Dickson USA 1828 Horlbeck USA 1880
Dumaresq USA 1828
Lehman West Indies 1828
Nicholson West Indies 1828
Bennett USA 1829
Lallement Brazil 1846
Thaly West Africa 1865
Christie East Africa 1871
Vauvray Egypt 1871
Dunkley India 1872
Sheriff India 1872
Sparrow India 1872
Wise India 1872
Cotholendy Reunion island 1873
Labonté Mauritius 1873
Morice Vietnam 1873

Second method: Application of a clinical score

An adapted diagnostic score was applied to the 31 selected articles, classifying 24 descriptions as CHIKV and 7 as DENV (Table 5). The epidemics classified as CHIKV included: 1779 in Indonesia, 1825 in India, 1827–1828 in the Americas, and 1871–1873 in the Indian Ocean. Three additional epidemics classified as CHIKV were isolated events: 1846 in Brazil, 1850 in the USA, and 1865 in West Africa.

Table 5. Application of the DENV-CHIKV diagnostic score to the 31 “dengue” epidemic descriptions included in the study.

Authors Region Year Total Result Arthritis
Bylon Indonesia 1779 2 CHIKV 1
Rush USA 1780 -1 DENV 0
Cubillas Spain 1784 0 DENV 0
De Castilla Spain 1784 -4 DENV 0
Ore India 1825 2 CHIKV 1
Cock West Indies 1827 5 CHIKV 0
Maxwell West Indies 1827 2 CHIKV 1
Ruan West Indies 1827 2 CHIKV 0
Squaer West Indies 1827 2 CHIKV 1
Stedman West Indies 1827 2 CHIKV 1
Dickson USA 1828 2 CHIKV 1
Dumaresq USA 1828 2 CHIKV 1
Lehman West Indies 1828 3 CHIKV 0
Nicholson West Indies 1828 2 CHIKV 1
Bennett USA 1829 3 CHIKV 0
Lallement Brazil 1846 3 CHIKV 1
Anderson USA 1850 2 CHIKV 0
Arnold USA 1850 -3 DENV 0
Campbell USA 1850 -9 DENV 0
Ballot West Indies 1860 -2 DENV 0
Thaly West Africa 1865 5 CHIKV 0
Christie East Africa 1871 4 CHIKV 1
Vauvray Egypt 1871 2 CHIKV 1
Dunkley India 1872 2 CHIKV 1
Sheriff India 1872 3 CHIKV 1
Sparrow India 1872 2 CHIKV 1
Wise India 1872 3 CHIKV 0
Cotholendy Reunion island 1873 2 CHIKV 0
Labonté Mauritius 1873 4 CHIKV 1
Morice Vietnam 1873 2 CHIKV 1
Horlbeck USA 1880 0 DENV 0

In contrast, DENV epidemics were more temporally dispersed: 1780 in Philadelphia, 1784 in Spain, 1850 in the USA, 1860 in the Caribbean, and 1880 in the USA. Joint swelling, a hallmark of Alphavirus infection, was reported in 71% (15/21) of the CHIKV-associated descriptions but was absent from the DENV group. Notably, 70% (15/21) of CHIKV-classified descriptions had a score of 2, which lies at the threshold of differentiation. This highlights the overlapping clinical presentations of the two diseases.

DENV infections were characterized by a higher prevalence of digestive and hemorrhagic symptoms, while joint pain, although prominent, was not exclusively indicative of CHIKV. The diagnostic score results aligned with expert opinion in 97% of cases (30/31). Only one outbreak failed to match the expert classification [38], due to insufficient reporting of DENV-specific symptoms, particularly hemorrhagic or digestive signs. Considering the context and the geographic proximity of the outbreak to other affected areas (Georgia and South Carolina), it was likely a DENV outbreak.

Third method: Double Proofreading by specialists in infectious and tropical diseases from French Guiana and mainland France

A review of the 31 articles was conducted by two groups of infectious and tropical disease specialists: one based in French Guiana (5 physicians) and the other in mainland France (7 physicians) (Table 6). According to this method, 61% (n = 19/31) of the diagnoses were concordant between the two groups, while 26% (n = 8/31) were discordant. In 13% of cases (n = 4/31), one of the reviewers indicated insufficient clinical evidence to reach a conclusion.

Table 6. Diagnoses retained after reading the 31 articles describing “dengue” epidemics in the 19th century.

Authors Region Year Diagnosis by score Mainland readers Guiana readers Discordance Diagnosis by expert opinion
Anderson USA 1850 CHIKV DENV DENV Yes DENV
Thaly West Africa 1865 CHIKV DENV DENV No CHIKV
Morice Vietnam 1873 CHIKV DENV DENV Yes CHIKV
Ore India 1825 CHIKV CHIKV DENV Yes CHIKV
Dumaresq USA 1828 CHIKV DENV CHIKV Yes CHIKV
Lehman West Indies 1828 CHIKV CHIKV DENV Yes CHIKV
Bennett USA 1829 CHIKV DENV CHIKV Yes CHIKV
Vauvray Egypt 1871 CHIKV DENV CHIKV Yes CHIKV
Sheriff India 1872 CHIKV DENV CHIKV Yes CHIKV
Cotholendy Reunion Island 1873 CHIKV DENV CHIKV Yes CHIKV
Horlbeck USA 1880 DENV DENV CHIKV Yes DENV
De Castilla Spain 1784 DENV NA DENV Yes DENV
Dickson USA 1828 CHIKV NA CHIKV Yes CHIKV
Ballot West Indies 1860 DENV NA DENV Yes DENV
Christie East Africa 1871 CHIKV CHIKV NA Yes CHIKV
Bylon Indonesia 1779 CHIKV CHIKV CHIKV No CHIKV
Rush USA 1780 DENV DENV DENV No DENV
Cubillas Spain 1784 DENV DENV DENV No DENV
Cock West Indies 1827 CHIKV CHIKV CHIKV No CHIKV
Maxwell West Indies 1827 CHIKV CHIKV CHIKV No CHIKV
Ruan West Indies 1827 CHIKV CHIKV CHIKV No CHIKV
Squaer West Indies 1827 CHIKV CHIKV CHIKV No CHIKV
Stedman West Indies 1827 CHIKV CHIKV CHIKV No CHIKV
Nicholson West Indies 1828 CHIKV CHIKV CHIKV No CHIKV
Lallement Brazil 1846 CHIKV CHIKV CHIKV No CHIKV
Arnold USA 1850 DENV DENV DENV No DENV
Campbell USA 1850 DENV DENV DENV No DENV
Dunkley India 1872 CHIKV CHIKV CHIKV No CHIKV
Sparrow India 1872 CHIKV CHIKV CHIKV No CHIKV
Wise India 1872 CHIKV CHIKV CHIKV No CHIKV
Labonté Mauritius 1873 CHIKV CHIKV CHIKV No CHIKV

Mainland readers correspond to readers practising in mainland France and Guiana readers to readers practising in French Guiana. In grey were figured situation when a reader was not able (NA) to propose a diagnosis, in red discordance between the 2 responses and orange discordance between reader results and diagnosis by score. DENV: Dengue virus, CHIKV: chikungunya virus.

Out of the 31 epidemic descriptions analyzed, 20 (65%) showed full agreement across all three methods (expert opinion, score, and both reviewer groups), consistently pointing to either CHIKV or DENV. These cases support the robustness of the combined approach. In contrast, 11 descriptions presented varying degrees of disagreement. In 8 of them, the reviewers from French Guiana and mainland France diverged in their classification; in 3 additional cases, there was disagreement between one or both reviewer groups and the clinical score. A comparison of the classifications made by the two groups of reviewers—those based in mainland France and those practicing in French Guiana—revealed a higher level of agreement with the expert opinion among the French Guiana group (83%) than among the mainland France group (75%) (Fig 3).

Fig 3. Concordance between diagnostic methods.

Fig 3

Figure legend: Cases with missing data (i.e., where one of the reviewers did not provide a diagnosis) were excluded from the analysis.

The underlying causes of discordance appear multifactorial, including limited clinical detail, ambiguities in symptom descriptions, or overlapping features such as the presence of fever and arthralgia without chronicity. These discrepancies highlight the intrinsic difficulty of diagnosing historical syndromes retrospectively without virological confirmation and support the need for a triangulated approach that cross-validates finding. Ultimately, this layered strategy provides a more nuanced interpretation of 19th-century epidemic data and illustrates the value of cross-methodological comparison in historical epidemiology.

Discussion

This study sought to retrospectively reclassify 18th and 19th century “dengue” epidemics using three diagnostic approaches. While these methods cannot replace biological confirmation—which is inherently impossible in this context—they each provide valuable insight. Concerning the first method, expert opinion is currently the most commonly used approach in historical studies of medicine. Despite its subjective nature, this approach allows for a comprehensive and contextual interpretation of historical medical texts. It enables the integration of linguistic nuances, social context, and clinical reasoning in the absence of standardized definitions or laboratory confirmation. Its continued use in the field reflects its relevance for reconstructing past medical events when objective data are lacking. This method is scientifically limited in robustness but allows for the development of plausible hypotheses. Notably, Dr. Carey and, later, researchers such as Dr. Halstead used this approach to challenge long-standing misconceptions from the 19th century — including the belief that there were no historical CHIKV epidemics, and the misuse of the term “dengue” prior to the advent of serological testing.

The clinical score allowed a standardized comparison based on reported symptoms, though it required detailed descriptions. It is important to note that the limitations of the diagnostic score are similar to those encountered in its contemporary use. The common clinical presentations of arboviral infections remain relatively comparable, and differentiation mainly relies on the presence of hemorrhagic signs for DENV—signs which are generally considered reliable in historical reports, as they were alarming and thus often described in detail. The presence of arthralgia in favor of CHIKV may be more debatable, especially in the early 19th century. However, most authors explicitly mention chronic joint pain. Rheumatism was well known and described at the time.

The dual review by physicians from two geographic and epidemiological backgrounds increased objectivity, but revealed substantial heterogeneity in interpretation. This difference may reflect the greater familiarity of French Guiana physicians with arboviral infections, which are endemic in their region. In contrast, reviewers from mainland France may be less frequently exposed to these infections in routine practice. It is also important to note that the expert opinion was provided by a physician practicing in French Guiana, and the diagnostic score was developed by authors also based in this region — which may represent a source of bias.

Regarding concordance, as noted, there appeared to be differences potentially linked to prior experience with arboviral infections. However, few consistent explanatory factors were identified. The presence of arthritis, for example, was not systematically interpreted as suggestive of CHIKV by reviewers. Dr. Morice’s account, which compared the “dengue” epidemic to gout attacks, was nonetheless classified as a probable DENV epidemic by both reviewers. Conversely, the 1850 epidemic described by Dr. Anderson was classified as CHIKV due to the presence of joint pain, even though no hemorrhagic signs were reported. Most full-agreement classifications were made in the context of detailed and comprehensive clinical descriptions. Unfortunately, regardless of the method used, each reader is inevitably influenced by the clinical lens of the original author. This is precisely why second-hand reports were excluded from the study—to minimize this inherent bias.

In summary, the analysis suggests that the epidemics of 1827–29 in the Americas and 1871–73 in the Indian Ocean may have been caused by chikungunya virus (CHIKV) rather than dengue virus (DENV). The consistent reports of disabling joint symptoms and swelling across multiple sources support this hypothesis. In contrast, the 1780 and 1850 outbreaks in the United States presented a more classical dengue-like syndrome, with hemorrhagic and digestive signs more typical of DENV infection. Some unexplained cases, such as the 1846 epidemic in Brazil, raise the question of whether other alphaviruses—such as Mayaro virus (MAYV), which is endemic in South America—might have been responsible, although MAYV has not been known to cause large-scale epidemics.

This retrospective approach carries important limitations. In particular, one must avoid the epistemological bias of presentism—the tendency to interpret historical phenomena through the lens of contemporary concepts and concerns. Although we applied modern nosological categories and Western medical standards to 19th-century descriptions, this period remains close to our present time, and modern biomedicine emerged from it [54]. Moreover, despite likely genetic variability, both CHIKV and DENV in the 19th century may have been clinically similar to the viruses we know today. This is supported by over 75 years of clinical observation showing remarkable consistency in symptomatology and transmission dynamics. While severe or atypical forms are better recognized today, the core presentation has not changed. Even now, in epidemic settings, clinical diagnosis remains widely used when molecular tools are limited.

The apparent underrepresentation of DENV outbreaks in our findings could be due to historical reporting bias. DENV likely circulated endemically in Asia and Africa during the 19th century, but Western physicians—mostly located in coastal trading posts—may have underreported its activity, particularly outside of large urban outbreaks. Endemic DENV may also have been confused with other febrile illnesses such as yellow fever or malaria. Conversely, CHIKV’s distinctive clinical profile and the size of its epidemics may have made it more visible in historical records. While other arboviruses such as O’nyong-nyong virus (ONNV) or Oropouche virus (OROV) have epidemic potential, only CHIKV and DENV have demonstrated repeated large-scale international spread. The recurring similarity in epidemic dynamics over the last two centuries suggests that lessons from the past may still be relevant for understanding present and future emerging diseases.

These methods could also be applied to later epidemics between 1880 and 1950, the etiology of which remains debated, as in the case of the 1900 epidemic in Singapore, which spread throughout South Asia and is still often attributed to dengue fever. However, its regional spread and limited clinical descriptions suggest that it may have been caused by CHIKV rather than DENV.

Conclusion

Recognizing the interpretative challenges in revisiting ancient medical texts, this study employed three distinct diagnostic methods. First, expert opinion provided a contextualized and comprehensive analysis but was subject to criticism due to its subjective nature. Second, the application of a clinical score allowed for greater objectivity and a more stringent diagnosis, although it was limited by the need for a complete description. Finally, proofreading by specialists contributed to greater objectivity but resulted in greater heterogeneity of results. When applied to descriptions of 19th-century “dengue” epidemics, all three methods were consistent in suggesting that a significant proportion of these epidemics were likely caused by CHIKV rather than DENV. The DENV epidemics were primarily those of 1780 in Philadelphia and 1850 in the southern United States, while the possible CHIKV epidemics were of a much larger scale, affecting the entire continental Americas in 1827–29, reminiscent of the 2013–15 epidemic, and the Indian Ocean and Indian subcontinent in 1871–73, reminiscent of the 2004–2006 epidemics.

Without modern serological or molecular tests, it was impossible to definitively diagnose these arboviruses. This raises the question of whether epidemics with “arthritic” symptoms were caused by CHIKV or an indigenous alphavirus like MAYV, which has a similar clinical profile but does not cause large-scale outbreaks like CHIKV. Current patterns point to CHIKV rather than MAYV. Studies have also shown that CHIKV epidemics in the 19th century led to the emergence of new strains [55]. While the 19th-century epidemics could be linked to CHIKV, certainty is impossible. This historical review is important, especially as researchers today search for the next emerging virus that could cause a pandemic.

Acknowledgments

Thanks to the teams from the Infectious and Tropical Diseases Department and the Clinical Investigation Center at Cayenne Hospital for their support in research on arboviruses. Thanks to Dr. Rousset from the Institut Pasteur of French Guiana.

Data Availability

All data used in the study are extracted from published historical sources, which are fully referenced in the bibliography of the manuscript.

Funding Statement

The author(s) received no specific funding for this work.

References

PLoS Negl Trop Dis. doi: 10.1371/journal.pntd.0013551.r001

Decision Letter 0

Joshua Anzinger

29 Apr 2025

Comparing Diagnostic Methods for Historical Arbovirus Outbreaks: Insights from 19th Century “dengue” Epidemics

PLOS Neglected Tropical Diseases

Dear Dr. Bonifay,

Thank you for submitting your manuscript to PLOS Neglected Tropical Diseases. After careful consideration, we feel that it has merit but does not fully meet PLOS Neglected Tropical Diseases's publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript within 60 days Jun 28 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosntds@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pntd/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

* A rebuttal letter that responds to each point raised by the editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'. This file does not need to include responses to any formatting updates and technical items listed in the 'Journal Requirements' section below.

* A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

* An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, competing interests statement, or data availability statement, please make these updates within the submission form at the time of resubmission. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

We look forward to receiving your revised manuscript.

Kind regards,

Joshua Anzinger

Academic Editor

PLOS Neglected Tropical Diseases

David Safronetz

Section Editor

PLOS Neglected Tropical Diseases

Shaden Kamhawi

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

orcid.org/0000-0003-4304-636XX

Paul Brindley

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

orcid.org/0000-0003-1765-0002

Additional Editor Comments:

The authors should ensure that all reviewer comments are addressed and that formatting of the manuscript is in accordance with PLOS Neglected Tropical Diseases guidelines.

Journal Requirements:

1) Please ensure that the CRediT author contributions listed for every co-author are completed accurately and in full.

At this stage, the following Authors/Authors require contributions: Timothee Bonifay, Mathieu Nacher, Clémence Bonnefoy, Benjamin Rossi, Edouard Hallet, Philippe Abboud, Guillaume Bellaud, Nathalie Dournon, Aurélia Henn, Adrien Lemaignen, Liem Binh Luong Nguyen, Diane Sanderink, Gaelle Walter, Alexandre Bleibtreu, and Loïc Epelboin. Please ensure that the full contributions of each author are acknowledged in the "Add/Edit/Remove Authors" section of our submission form.

The list of CRediT author contributions may be found here: https://journals.plos.org/plosntds/s/authorship#loc-author-contributions

2) Please provide an Author Summary. This should appear in your manuscript between the Abstract (if applicable) and the Introduction, and should be 150-200 words long. The aim should be to make your findings accessible to a wide audience that includes both scientists and non-scientists. Sample summaries can be found on our website under Submission Guidelines:

https://journals.plos.org/plosntds/s/submission-guidelines#loc-parts-of-a-submission

3) Please upload all main figures as separate Figure files in .tif or .eps format. For more information about how to convert and format your figure files please see our guidelines: 

https://journals.plos.org/plosntds/s/figures

4) We note that your Data Availability Statement is currently as follows: "All data used in the study are available online.". Please confirm at this time whether or not your submission contains all raw data required to replicate the results of your study. Authors must share the “minimal data set” for their submission. PLOS defines the minimal data set to consist of the data required to replicate all study findings reported in the article, as well as related metadata and methods (https://journals.plos.org/plosone/s/data-availability#loc-minimal-data-set-definition).

For example, authors should submit the following data: 

- The values behind the means, standard deviations and other measures reported;

- The values used to build graphs;

- The points extracted from images for analysis..

Authors do not need to submit their entire data set if only a portion of the data was used in the reported study.

If your submission does not contain these data, please either upload them as Supporting Information files or deposit them to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of recommended repositories, please see https://journals.plos.org/plosone/s/recommended-repositories. 

If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. If data are owned by a third party, please indicate how others may request data access.

Reviewers' Comments:

Reviewer's Responses to Questions

Key Review Criteria Required for Acceptance?

As you describe the new analyses required for acceptance, please consider the following:

Methods

-Are the objectives of the study clearly articulated with a clear testable hypothesis stated?

-Is the study design appropriate to address the stated objectives?

-Is the population clearly described and appropriate for the hypothesis being tested?

-Is the sample size sufficient to ensure adequate power to address the hypothesis being tested?

-Were correct statistical analysis used to support conclusions?

-Are there concerns about ethical or regulatory requirements being met?

Reviewer #1: (No Response)

Reviewer #2: (No Response)

Reviewer #3: yes. But, the authors historical debt to other writers has not been acknowledged.

**********

Results

-Does the analysis presented match the analysis plan?

-Are the results clearly and completely presented?

-Are the figures (Tables, Images) of sufficient quality for clarity?

Reviewer #1: (No Response)

Reviewer #2: (No Response)

Reviewer #3: yes

**********

Conclusions

-Are the conclusions supported by the data presented?

-Are the limitations of analysis clearly described?

-Do the authors discuss how these data can be helpful to advance our understanding of the topic under study?

-Is public health relevance addressed?

Reviewer #1: (No Response)

Reviewer #2: (No Response)

Reviewer #3: yes

**********

Editorial and Data Presentation Modifications?

Use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity. If the only modifications needed are minor and/or editorial, you may wish to recommend “Minor Revision” or “Accept”.

Reviewer #1: (No Response)

Reviewer #2: (No Response)

Reviewer #3: comments and suggestions are made in other locations.

**********

Summary and General Comments

Use this section to provide overall comments, discuss strengths/weaknesses of the study, novelty, significance, general execution and scholarship. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. If requesting major revision, please articulate the new experiments that are needed.

Reviewer #1: This manuscript by Bonifay and colleagues presenting an interesting historical analysis of past outbreaks of "dengue", for which the authors investigate evidence that they were actually caused by dengue virus, chikungunya virus, or possible other pathogens. This is a topic that frequently comes into discussion in the field, and hence the authors systematic approach to the question is a useful contribution to the field. Generally, they acknowledge and accept the various limitations of such an endeavor and do not overstate their findings or conclusions. Nonetheless, several revisions are needed:

1) Section 2.4: the authors state that "Each article was independently reviewed by one physician from each [adjudication] group, ensuring two readings per article. After reviewing the articles, the adjudicators categorized them". It is not clear from this if each article was categorized by the two physicians reviewing the article, or if the physicians presented their interpretation to the adjudication committee who then together determined the categorization, or something else. Additional information is needed to clarify this process. Of note, if only one physician classified each article for each committee, it calls into question the validity and utility of this part of the overall study.

2) The calculation of sensitivity, specificity, and accuracy should be removed from the manuscript, as there is no "gold standard" by which to compare any of the analytic components of this study. One could make a case for any of the three parts (scoring, readings, proofreading) to be compared to any other - I see no reason why the expert opinion proofreading should be seen as the most correct and used as the comparator. That said, I would appreciate if the authors were to present an analysis of which outbreaks were determined to be most likely caused by CHIKV or DENV via agreement of all three methods vs. those for which there were disagreement. (The authors present some such comparison already, but not agreement between all methods.)

3) The format of the manuscript as a whole is atypical and (subject to the direction of the journal editors) may require significant re-formatting. Of note:

a) The use of numbered section headings (1, 2.3, 3.2.4, etc.) is not typical. Standard headings (Introduction, Materials and Methods, etc.) followed by non-numbered headings may be of greater utility to the reader.

b) The abstract does not follow the standard format of Intro/Methods/Results/Conclusions. I defer to the editors to determine if re-formatting is required or if the current format is acceptable.

c) Lines 230-232 belong in the Discussion.

d) Lines 251-255 belong in the Discussion.

e) Section 4 (Limitations) should be a component of the Discussion, not a free-standing section.

Reviewer #2: In this article, Bonifay et al attempt to assign the probably causal infectious etiology of multiple historic “dengue” outbreaks. Using a series of literature reviews, scoring metrics, and input from current infectious disease clinicians, the authors posit that many historic “dengue” outbreaks that occurred before the identification of DENV may have been caused by other arboviruses, such as CHIKV.

My most significant concern with the methodology utilized in this study is that the clinical presentation of arboviral infections – such as DENV and CHIKV – can vary significantly over time and in different regions of the world, and additionally based on the exposure history of the population being examined. I have no doubt that the experts polled in this study are extremely competent in identifying the clinical symptoms of modern DENV and CHIKV infections, but it seems like a significant leap to assume that the clinical presentation of these infections would be identical 200+ years ago given wide variation in clinical presentation we see today. We know from modern serostudies that clinical diagnosis of even modern DENV infections can be very hit-or-miss without molecular, serologic, and/or antigenic diagnostics. It seems hard to believe that 2nd/3rd-hand diagnosis would be any more accurate.

Reviewer #3: The authors have compiled a reasonably complete bibliography of the nearly 250-year-old literature describing outbreaks of short duration febrile diseases caused by chikungunya and dengue viruses. It is not merely confusing, but somewhat short-shrifting for the authors to fail to preface this review by acknowledging dengue-expert Donald Carey’s 1970 trip to the Harvard Library where he had recognized that the 1779 “dengue” epidemic in Batavia, New Netherlands closely resembled chikungunya febrile disease. In the medical literature, it had long been labeled an outbreak of dengue. From this insight, he wrote “Chikungunya and “dengue,” a case of mistaken identity?” published in 1971. Equally important, a report by another arbovirologist, Scott Halstead, published in 2015, recognized that chikungunya in the Caribbean was a reappearance of a chikungunya virus that had been transported from East Africa in 1827 to the Caribbean where the disease it caused had been given the name, “dengue.” This article, rich in historical details, was published in 2015.

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy .

Reviewer #1: No

Reviewer #2: No

Reviewer #3: Yes:  Scott B Halstead

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

Figure resubmission:

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. If there are other versions of figure files still present in your submission file inventory at resubmission, please replace them with the PACE-processed versions.

Reproducibility:

?>

PLoS Negl Trop Dis. doi: 10.1371/journal.pntd.0013551.r003

Decision Letter 1

Joshua Anzinger

11 Aug 2025

Comparing Diagnostic Methods for Historical Arbovirus Outbreaks: Insights from 19th Century “dengue” Epidemics

PLOS Neglected Tropical Diseases

Dear Dr. Bonifay,

Thank you for submitting your manuscript to PLOS Neglected Tropical Diseases. After careful consideration, we feel that it has merit but does not fully meet PLOS Neglected Tropical Diseases's publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript within 30 days Sep 10 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosntds@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pntd/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

* A rebuttal letter that responds to each point raised by the editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers '. This file does not need to include responses to any formatting updates and technical items listed in the 'Journal Requirements' section below.

* A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes '.

* An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript '.

If you would like to make changes to your financial disclosure, competing interests statement, or data availability statement, please make these updates within the submission form at the time of resubmission. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

We look forward to receiving your revised manuscript.

Kind regards,

Joshua Anzinger

Academic Editor

PLOS Neglected Tropical Diseases

David Safronetz

Section Editor

PLOS Neglected Tropical Diseases

Shaden Kamhawi

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

orcid.org/0000-0003-4304-636XX

Paul Brindley

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

orcid.org/0000-0003-1765-0002

Additional Editor Comments:

Please address Reviewer 3’s comments completely.

Journal Requirements:

If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise.

Reviewers' comments:

Reviewer's Responses to Questions

Key Review Criteria Required for Acceptance?

As you describe the new analyses required for acceptance, please consider the following:

Methods

-Are the objectives of the study clearly articulated with a clear testable hypothesis stated?

-Is the study design appropriate to address the stated objectives?

-Is the population clearly described and appropriate for the hypothesis being tested?

-Is the sample size sufficient to ensure adequate power to address the hypothesis being tested?

-Were correct statistical analysis used to support conclusions?

-Are there concerns about ethical or regulatory requirements being met?

Reviewer #1: (No Response)

Reviewer #3: Okay

**********

Results

-Does the analysis presented match the analysis plan?

-Are the results clearly and completely presented?

-Are the figures (Tables, Images) of sufficient quality for clarity?

Reviewer #1: (No Response)

Reviewer #3: yes

**********

Conclusions

-Are the conclusions supported by the data presented?

-Are the limitations of analysis clearly described?

-Do the authors discuss how these data can be helpful to advance our understanding of the topic under study?

-Is public health relevance addressed?

Reviewer #1: (No Response)

Reviewer #3: yes

**********

Editorial and Data Presentation Modifications?

Use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity. If the only modifications needed are minor and/or editorial, you may wish to recommend “Minor Revision” or “Accept”.

Reviewer #1: (No Response)

Reviewer #3: The reviewer offers as a “gift” sentences from his own history of chikungunya. “The names, “Dengue” and “dengue fever” were attached to distinct short-duration febrile diseases before their viral etiology was established. The clinical term “dengue” entered the medical literature in the American hemisphere in the 19th century describing a short-duration febrile exanthem. It was not an English word, but a Spanish homonym of the African Swahili “kidinga pepo,” sometimes pronounced “denga” or “dyenga” This was the name given to epidemics of a disabling febrile arthritis, now known as chikungunya, during outbreaks in East Africa in 1823 and again in 1870. (1) In 1881, James Christie, a Scottish-trained physician attached to the Sultan of Zanzibar, in the 1860s-70s published a report explicitly linking an 1823 East African outbreak of kidinga pepo to the outbreak in 1827 – 28 of “dengue” in the Americas. (2) In commenting on the dispersal of what we now know to be chikungunya virus, Christie described reports that the 1823 Zanzibar epidemic had spread East to Gujarat, India, then on to Calcutta and in 1824 to Rangoon. He added that there had been a similar spread of the 1823 “dengue” epidemic, this time westwards. In 1827, this epidemic reached St.Thomas in the West Indies. Christie states “I am of the opinion that both the disease and its designation were imported in the West Indian Islands direct from the East Coast of Africa.” (2) He noted it was then that the medical term “dengue” was introduced into the West Indies as a Spanish homynym of the African word. Another observer, contemporary to the West Indian epidemic, agreed. He wrote: “when the dengue” reached New Orleans in 1828, “the disease alluded to is supposed to have been brought from Africa, with some slaves imported into the Havana. In that place it obtained the name of Dingee, Dengue, Danga, etc. It was there very prevalent and also in Barbadoes, where it received the name of Dandy fever, from the stiffened form and dread of motion in patients.” (3)

1. Christie J. Remarks on "kidinga Pepo"' a peculiar form of exantematous disease. Epidemic in Zanzibar, East Coast of Africa, from July 1870 till January 1871. BMJ. 1872;1:577-79.

2. Christie J. On epidemics of dengue fever: their diffusion and etiology. Glasgow Med J. 1881;3:161-76.

3. Dumaresq PJ. An account of dengue, danga or dandy fever, as it occurred in New Orleans and in the person of the writer,communicated in a letter to one of the editors. . Boston Medical and Surgical Journal. 1828;1:497-502.

The reviewer hopes the authors will take the time to investigate the outbreak of 1900 in Singapore which extended throughout southern Asia. This has been confused over and over as caused by a dengue virus. Clearly, it is chikungunya. Remember, chikungunya is an African zoonosis that spills over into an urban cycle on the East coast of Africa at approximately 40 year intervals. It has made the transit across the Indian Ocean many, many times.

**********

Summary and General Comments

Use this section to provide overall comments, discuss strengths/weaknesses of the study, novelty, significance, general execution and scholarship. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. If requesting major revision, please articulate the new experiments that are needed.

Reviewer #1: My comments have been adequately addressed. I still have minor concerns about the format of the manuscript, but those can be addressed by the editorial staff during subsequent steps.

Reviewer #3: As suggested, this history could be expanded, helping the dengue community better understand its past.

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy .

Reviewer #1: No

Reviewer #3: No

Figure resubmission:

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. If there are other versions of figure files still present in your submission file inventory at resubmission, please replace them with the PACE-processed versions.

Reproducibility:

To enhance the reproducibility of your results, we recommend that authors of applicable studies deposit laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

PLoS Negl Trop Dis. doi: 10.1371/journal.pntd.0013551.r005

Decision Letter 2

Joshua Anzinger

9 Sep 2025

Dear Dr. Bonifay,

We are pleased to inform you that your manuscript 'Comparing Diagnostic Methods for Historical Arbovirus Outbreaks: Insights from 19th Century “dengue” Epidemics' has been provisionally accepted for publication in PLOS Neglected Tropical Diseases.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases.

Best regards,

Joshua Anzinger

Academic Editor

PLOS Neglected Tropical Diseases

David Safronetz

Section Editor

PLOS Neglected Tropical Diseases

Shaden Kamhawi

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

orcid.org/0000-0003-4304-636XX

Paul Brindley

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

orcid.org/0000-0003-1765-0002

***********************************************************

p.p1 {margin: 0.0px 0.0px 0.0px 0.0px; line-height: 16.0px; font: 14.0px Arial; color: #323333; -webkit-text-stroke: #323333}span.s1 {font-kerning: none

PLoS Negl Trop Dis. doi: 10.1371/journal.pntd.0013551.r006

Acceptance letter

Joshua Anzinger

Dear Dr. Bonifay,

We are delighted to inform you that your manuscript, "Comparing Diagnostic Methods for Historical Arbovirus Outbreaks: Insights from 19th Century “dengue” Epidemics," has been formally accepted for publication in PLOS Neglected Tropical Diseases.

We have now passed your article onto the PLOS Production Department who will complete the rest of the publication process. All authors will receive a confirmation email upon publication.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any scientific or type-setting errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript. Note: Proofs for Front Matter articles (Editorial, Viewpoint, Symposium, Review, etc...) are generated on a different schedule and may not be made available as quickly.

Soon after your final files are uploaded, the early version of your manuscript will be published online unless you opted out of this process. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing.

Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases.

Best regards,

Shaden Kamhawi

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

Paul Brindley

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Attachment

    Submitted filename: Response to Reviewers v2.0.docx

    pntd.0013551.s002.docx (2.6MB, docx)
    Attachment

    Submitted filename: Response to Reviewers.docx

    pntd.0013551.s003.docx (16.9KB, docx)

    Data Availability Statement

    All data used in the study are extracted from published historical sources, which are fully referenced in the bibliography of the manuscript.


    Articles from PLOS Neglected Tropical Diseases are provided here courtesy of PLOS

    RESOURCES